Join
Live feed
·
PRReleasevia Quantisnow
BriaCell Therapeutics Corp. logo

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCTX (BriaCell Therapeutics Corp.) and more on Quantisnow.